Clinical trials
Completed Muscular Dystrophy, Facioscapulohumeral trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2010 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2019 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire de Nice | 4 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Grete Andersen, MD | 1 |
| King's College Hospital NHS Trust | 1 |
| McGill University | 1 |
| Murdoch Childrens Research Institute | 1 |
| Ohio State University | 1 |
| Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust | 1 |
| Seoul National University Hospital | 1 |
| Swiss Federal Institute of Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Muscular Dystrophy, Facioscapulohumeral | 15 |
| Muscular Dystrophies | 3 |
| Muscular Dystrophy, Duchenne | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Genetic Diseases, Inborn | 1 |
| Mental Disorders | 1 |
| Muscle Weakness | 1 |
| Muscular Atrophy, Spinal | 1 |
| Muscular Dystrophies, Limb-Girdle | 1 |
| Myositis, Inclusion Body | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.